Doctors Clinical Laboratory INC
Doctors Clinical Laboratory INC was paid $398K by Medicaid between Jan 2018 and Dec 2021, across 22 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 45% of everything it billed.
ROLLING MEADOWS, IL 60008
Next to other Clinical Medical Laboratory providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,904 | $15K | |
| 2019 | 203 | $2K | |
| 2020 | 157 | $2K | |
| 2021 | 12,842 | $380K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 45% | 2,707 | 2,445 | $180K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 19% | 3,969 | 3,397 | $75K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 16% | 2,120 | 1,921 | $63K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 15% | 2,715 | 2,455 | $62K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 276 | 233 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 569 | 482 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 333 | 268 | $3K |
| 80061 | Lipid panel | <1% | 273 | 203 | $1K |
| 86677 | <1% | 86 | 70 | $1K | |
| 84436 | <1% | 152 | 121 | $973.49 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 71 | 51 | $666.68 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 95 | 75 | $631.06 |
10 more codes
| 86038 | <1% | 41 | $629.47 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 14 | $487.97 |
| 81000 | <1% | 183 | $450.47 | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 15 | $377.07 |
| 85651 | <1% | 72 | $322.82 | |
| 84479 | <1% | 37 | $210.40 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 43 | $120.25 |
| 84550 | <1% | 15 | $64.38 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 21 | $53.58 |
| 99072 | <1% | 1,299 | $32.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.